Magnesiocard

Magnesium Aspartate Hydrochloride, the active ingredient in Magnesiocard, is a magnesium supplement presented as an intravenous solution for intravenous use. It is employed to treat magnesium deficiency and hypomagnesemia in patients requiring rapid correction of low serum magnesium levels.

GNH USA supplies Magnesiocard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnesiocard is used to address conditions related to low magnesium levels and associated electrolyte disturbances.

- Magnesium deficiency: restores normal magnesium concentrations in patients with inadequate dietary intake or losses. - Hypomagnesemia: rapidly corrects low serum magnesium in acute care settings. - Electrolyte imbalance: supports overall electrolyte homeostasis during critical illness or postoperative recovery.

Magnesiocard may be associated with a range of adverse reactions following intravenous administration.

Common Side Effects: - Flushing or warmth at the infusion site. - Nausea or mild gastrointestinal discomfort. - Headache or dizziness. - Transient hypotension during rapid infusion. - Mild muscle weakness.

Serious or Rare Side Effects: - Severe hypotension or cardiovascular collapse. - Cardiac arrhythmias, including bradycardia. - Respiratory depression or apnea. - Hypermagnesemia leading to neuromuscular blockade. - Anaphylactic or severe allergic reactions.

When using Magnesiocard, clinicians should observe several safety measures.

- Assess baseline serum magnesium: confirm deficiency before infusion. - Monitor cardiac rhythm: watch for arrhythmias during and after administration. - Adjust dose in renal impairment: reduced clearance may increase risk of hypermagnesemia. - Avoid rapid infusion: administer over the recommended time to prevent hypotension. - Use aseptic technique: maintain sterility of the IV solution. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesiocard can interact with other medications, requiring careful management.

Major Interactions (Avoid): - Neuromuscular blocking agents: may potentiate muscle relaxation and respiratory depression. - Calcium channel blockers: additive effects on cardiac conduction and blood pressure. - Digoxin: increased risk of toxicity due to altered electrolyte balance.

Moderate Interactions (Monitor Closely): - Loop diuretics: may enhance magnesium loss, requiring dose adjustments. - ACE inhibitors: potential for additive hypotensive effects. - Aminoglycoside antibiotics: increased risk of nephrotoxicity and altered magnesium handling.